Breaking News, Collaborations & Alliances

Axovant Partners with Viralgen

Supports the development and commercialization of Axovant’s AAV gene therapy programs.

By: Contract Pharma

Contract Pharma Staff

Axovant Gene Therapies Ltd has signed a strategic partnership with Viralgen, a contract development and manufacturing organization (CDMO). Leveraging the technology platforms of AskBio, Viralgen is able to support all aspects of manufacturing for Axovant’s AAV programs, including large-scale manufacturing, fill-finish, and quality control in a GMP-certified environment designed to bring therapies to market as quickly as possible.   Under the terms of the partnership, Axovant will have access to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters